| 5.3 |
21.4 |
GO:2000974 |
negative regulation of pro-B cell differentiation(GO:2000974) |
| 4.3 |
12.8 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 3.8 |
11.5 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 3.5 |
17.3 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 2.9 |
8.7 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 2.5 |
10.0 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 2.5 |
7.4 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 2.5 |
7.4 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 2.4 |
7.1 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 2.3 |
7.0 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 2.3 |
11.4 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 2.3 |
11.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 2.2 |
6.5 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil activation(GO:1902566) |
| 2.2 |
15.1 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 2.1 |
6.4 |
GO:0060217 |
hemangioblast cell differentiation(GO:0060217) |
| 2.0 |
6.0 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 2.0 |
23.6 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 1.9 |
9.6 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 1.9 |
5.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.9 |
9.3 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 1.8 |
1.8 |
GO:2000977 |
regulation of forebrain neuron differentiation(GO:2000977) |
| 1.8 |
5.5 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 1.7 |
7.0 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 1.7 |
7.0 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 1.7 |
5.2 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.7 |
5.2 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 1.7 |
8.6 |
GO:0019659 |
lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 1.7 |
5.1 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 1.6 |
6.3 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 1.6 |
12.6 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.6 |
1.6 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 1.5 |
7.5 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 1.4 |
5.8 |
GO:0032901 |
positive regulation of neurotrophin production(GO:0032901) |
| 1.4 |
13.0 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 1.4 |
7.2 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 1.4 |
6.9 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 1.4 |
8.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.4 |
5.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 1.4 |
6.8 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 1.3 |
6.7 |
GO:0032962 |
positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 1.3 |
3.9 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 1.3 |
5.3 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
| 1.3 |
3.9 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 1.3 |
3.9 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 1.3 |
3.9 |
GO:0007521 |
muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
| 1.3 |
6.4 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 1.3 |
5.1 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 1.3 |
2.5 |
GO:0014891 |
striated muscle atrophy(GO:0014891) |
| 1.3 |
12.6 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 1.2 |
12.4 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 1.2 |
5.0 |
GO:2000256 |
positive regulation of male germ cell proliferation(GO:2000256) |
| 1.2 |
3.7 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 1.2 |
7.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 1.2 |
4.9 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.2 |
6.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 1.2 |
3.7 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.2 |
3.6 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 1.2 |
2.4 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 1.2 |
3.6 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 1.2 |
4.7 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 1.2 |
12.9 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 1.2 |
4.7 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 1.1 |
3.2 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 1.1 |
4.3 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 1.0 |
5.2 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 1.0 |
13.4 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 1.0 |
3.0 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 1.0 |
9.0 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 1.0 |
3.0 |
GO:0090032 |
negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 1.0 |
14.7 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 1.0 |
2.9 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 1.0 |
7.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.9 |
2.8 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.9 |
3.8 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.9 |
5.6 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.9 |
5.6 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.9 |
2.8 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.9 |
2.8 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.9 |
8.3 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.9 |
0.9 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.9 |
2.7 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.9 |
3.5 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.9 |
4.4 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 0.9 |
2.6 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.9 |
6.1 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.9 |
3.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.9 |
6.9 |
GO:1901550 |
regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.9 |
4.3 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.8 |
5.1 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.8 |
0.8 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.8 |
2.5 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.8 |
1.6 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.8 |
2.4 |
GO:0048818 |
embryonic nail plate morphogenesis(GO:0035880) positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) frontal suture morphogenesis(GO:0060364) |
| 0.8 |
2.4 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.8 |
4.0 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.8 |
2.4 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.8 |
1.6 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.8 |
9.3 |
GO:0009437 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
| 0.8 |
3.9 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.8 |
4.6 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.8 |
5.4 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.8 |
0.8 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.8 |
5.4 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.8 |
2.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.7 |
5.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.7 |
2.2 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.7 |
2.2 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.7 |
2.9 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.7 |
3.6 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.7 |
2.8 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.7 |
0.7 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 0.7 |
2.1 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.7 |
0.7 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.7 |
2.8 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) resolution of recombination intermediates(GO:0071139) |
| 0.7 |
7.0 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.7 |
16.7 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.7 |
7.0 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.7 |
6.2 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.7 |
2.1 |
GO:0010814 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.7 |
6.2 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.7 |
3.4 |
GO:0043173 |
purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) nucleotide salvage(GO:0043173) |
| 0.7 |
6.8 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.7 |
4.6 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.7 |
1.3 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.6 |
5.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.6 |
0.6 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.6 |
1.2 |
GO:0046618 |
drug export(GO:0046618) |
| 0.6 |
1.8 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.6 |
5.4 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.6 |
3.0 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.6 |
2.4 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.6 |
1.8 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 0.6 |
5.4 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.6 |
33.9 |
GO:0051384 |
response to glucocorticoid(GO:0051384) |
| 0.6 |
5.3 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.6 |
1.8 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.6 |
3.5 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.6 |
2.3 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.6 |
1.2 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.6 |
3.5 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.6 |
5.2 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.6 |
3.4 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.6 |
3.4 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.6 |
0.6 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.6 |
2.8 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.6 |
4.0 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.6 |
5.6 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.6 |
1.1 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.6 |
13.8 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.5 |
3.3 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.5 |
1.6 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.5 |
2.7 |
GO:2000680 |
regulation of rubidium ion transport(GO:2000680) |
| 0.5 |
9.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.5 |
1.6 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.5 |
2.1 |
GO:0006203 |
dGTP catabolic process(GO:0006203) dATP catabolic process(GO:0046061) |
| 0.5 |
2.1 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.5 |
2.1 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.5 |
1.0 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.5 |
6.1 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.5 |
1.5 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.5 |
2.5 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.5 |
3.4 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.5 |
1.4 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.5 |
2.9 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.5 |
1.9 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.5 |
4.2 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.5 |
2.3 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.5 |
0.5 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.5 |
0.9 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.5 |
1.8 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.5 |
3.2 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.4 |
0.9 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
| 0.4 |
0.9 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.4 |
0.4 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.4 |
2.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.4 |
1.3 |
GO:0035696 |
monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.4 |
1.3 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.4 |
0.4 |
GO:2000136 |
regulation of cell proliferation involved in heart morphogenesis(GO:2000136) |
| 0.4 |
4.3 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.4 |
3.0 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.4 |
5.5 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.4 |
2.6 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 |
3.8 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.4 |
1.3 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.4 |
2.1 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.4 |
6.3 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.4 |
3.3 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.4 |
0.8 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.4 |
2.5 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.4 |
2.4 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.4 |
1.2 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.4 |
5.6 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.4 |
3.2 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.4 |
2.0 |
GO:0071493 |
creatinine metabolic process(GO:0046449) cellular response to UV-B(GO:0071493) cellular lactam metabolic process(GO:0072338) |
| 0.4 |
9.9 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.4 |
2.0 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.4 |
1.2 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.4 |
10.2 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.4 |
5.0 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.4 |
2.7 |
GO:1904707 |
regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.4 |
2.3 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.4 |
9.6 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.4 |
1.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.4 |
3.0 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.4 |
1.1 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.4 |
3.4 |
GO:0019400 |
glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
| 0.4 |
2.3 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.4 |
2.6 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.4 |
2.3 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.4 |
1.9 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.4 |
4.9 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.4 |
2.6 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.4 |
1.5 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.4 |
1.8 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.4 |
1.1 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.4 |
2.6 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.4 |
10.9 |
GO:0035136 |
forelimb morphogenesis(GO:0035136) |
| 0.4 |
2.9 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.4 |
4.0 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.4 |
1.5 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.4 |
1.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.4 |
2.5 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.4 |
1.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.3 |
7.3 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.3 |
0.7 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 0.3 |
1.7 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.3 |
2.1 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.3 |
4.9 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.3 |
3.5 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 |
0.7 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.3 |
1.0 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.3 |
1.7 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.3 |
1.4 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.3 |
2.4 |
GO:0061620 |
glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.3 |
2.7 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.3 |
2.7 |
GO:0001996 |
regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
| 0.3 |
3.0 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.3 |
3.9 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.3 |
1.0 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.3 |
1.9 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.3 |
1.6 |
GO:0009448 |
gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.3 |
1.9 |
GO:0006573 |
valine metabolic process(GO:0006573) |
| 0.3 |
1.0 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
1.9 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 |
0.6 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.3 |
2.2 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.3 |
10.8 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.3 |
1.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
1.6 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 |
1.6 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.3 |
1.6 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.3 |
1.6 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.3 |
3.4 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.3 |
0.9 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.3 |
1.8 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.3 |
0.9 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.3 |
3.9 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 |
3.6 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.3 |
1.5 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.3 |
0.9 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.3 |
0.9 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.3 |
1.2 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.3 |
1.8 |
GO:0002154 |
thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.3 |
2.0 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.3 |
1.7 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.3 |
9.4 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.3 |
0.6 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.3 |
1.7 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.3 |
1.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.3 |
2.2 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.3 |
1.1 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.3 |
0.8 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.3 |
1.1 |
GO:0060315 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.3 |
6.8 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.3 |
2.4 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.3 |
1.6 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.3 |
3.8 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.3 |
0.3 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.3 |
0.8 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.3 |
1.3 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.3 |
0.8 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.3 |
0.5 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.3 |
1.3 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.3 |
0.8 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.3 |
1.6 |
GO:0070989 |
oxidative demethylation(GO:0070989) |
| 0.3 |
3.3 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.3 |
0.8 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.3 |
1.3 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.3 |
0.8 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.3 |
1.3 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.3 |
1.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.3 |
9.6 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.3 |
2.0 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
0.7 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.2 |
0.5 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.2 |
1.2 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.2 |
3.2 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.2 |
9.1 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.2 |
1.2 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.2 |
2.9 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.2 |
1.0 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.2 |
5.7 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.2 |
0.5 |
GO:2000097 |
regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.2 |
0.9 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
0.9 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.2 |
0.5 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.2 |
8.8 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.2 |
0.5 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.2 |
11.2 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.2 |
0.9 |
GO:0010510 |
regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.2 |
4.3 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.2 |
0.7 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
3.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.2 |
6.2 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.2 |
2.4 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.2 |
5.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.2 |
1.5 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 |
2.0 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.2 |
4.1 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.2 |
2.6 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 |
1.1 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
1.9 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 |
0.6 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.2 |
0.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.2 |
1.7 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
0.8 |
GO:0044828 |
negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 |
4.0 |
GO:1902622 |
regulation of neutrophil migration(GO:1902622) |
| 0.2 |
3.5 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.2 |
0.6 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.2 |
1.6 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.2 |
2.6 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 |
1.6 |
GO:0030539 |
male genitalia development(GO:0030539) plasminogen activation(GO:0031639) |
| 0.2 |
0.6 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.2 |
0.6 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.2 |
1.4 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 |
3.1 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.2 |
3.1 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.2 |
1.3 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.2 |
0.6 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.2 |
3.8 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.2 |
1.7 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.2 |
0.6 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.2 |
1.9 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
5.2 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.2 |
1.5 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.2 |
0.6 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 |
6.0 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.2 |
0.2 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
0.9 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.2 |
0.4 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.2 |
1.6 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.2 |
10.4 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.2 |
2.8 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.2 |
0.2 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.2 |
0.3 |
GO:0032960 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
| 0.2 |
3.3 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.2 |
1.9 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.2 |
0.7 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.2 |
0.8 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 |
1.0 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.2 |
0.7 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
0.5 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.2 |
5.0 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
2.3 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.2 |
1.1 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.2 |
1.0 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
1.0 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.2 |
1.1 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 |
4.8 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.2 |
1.4 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
1.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
0.5 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.2 |
0.6 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.2 |
0.9 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
0.9 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
0.9 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.2 |
1.4 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.4 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.4 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
3.5 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
2.2 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.1 |
1.2 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.1 |
2.6 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
1.1 |
GO:0060261 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
4.1 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 |
8.4 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
0.6 |
GO:0033262 |
regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 |
1.8 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
1.4 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.1 |
3.0 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.1 |
0.8 |
GO:2001198 |
regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
3.1 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.1 |
0.7 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
0.7 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.1 |
6.0 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.4 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.9 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
1.1 |
GO:0045823 |
positive regulation of heart contraction(GO:0045823) |
| 0.1 |
1.6 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.5 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.1 |
1.1 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 |
0.6 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
2.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
3.6 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.1 |
0.9 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.5 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.9 |
GO:0046825 |
regulation of protein export from nucleus(GO:0046825) |
| 0.1 |
0.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.5 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 |
1.4 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.1 |
2.4 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
1.7 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
1.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.8 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
1.7 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
0.7 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
0.3 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.1 |
0.5 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 |
0.3 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 |
0.6 |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
| 0.1 |
0.6 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.5 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
3.2 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
| 0.1 |
0.5 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
1.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.1 |
0.3 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.1 |
2.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.7 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.1 |
0.3 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.1 |
0.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.5 |
GO:0002281 |
macrophage activation involved in immune response(GO:0002281) |
| 0.1 |
0.3 |
GO:0038089 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) protein kinase D signaling(GO:0089700) |
| 0.1 |
0.6 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.1 |
0.8 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
0.2 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.1 |
2.8 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.1 |
0.3 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
0.5 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.1 |
2.5 |
GO:0016575 |
histone deacetylation(GO:0016575) |
| 0.1 |
0.3 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.4 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.8 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 |
1.3 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.1 |
1.0 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.5 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
1.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.1 |
1.4 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.1 |
0.3 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
1.7 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.1 |
2.9 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
1.5 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 |
0.5 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 |
0.3 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 |
2.5 |
GO:0051928 |
positive regulation of calcium ion transport(GO:0051928) |
| 0.1 |
1.1 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.7 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
1.9 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
1.5 |
GO:0007099 |
centriole replication(GO:0007099) |
| 0.1 |
0.2 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 |
0.2 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.1 |
11.0 |
GO:0000082 |
G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.1 |
0.4 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
0.2 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
0.7 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.1 |
0.6 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.7 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.1 |
2.5 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.1 |
0.5 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.1 |
0.5 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
3.3 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
1.0 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
0.6 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 |
1.3 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
0.8 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 |
0.8 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.1 |
0.3 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.1 |
0.5 |
GO:0000467 |
exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
| 0.1 |
1.7 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.5 |
GO:0060760 |
positive regulation of response to cytokine stimulus(GO:0060760) |
| 0.1 |
0.7 |
GO:0001678 |
cellular glucose homeostasis(GO:0001678) |
| 0.1 |
0.7 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
1.4 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.1 |
GO:0061156 |
pulmonary artery morphogenesis(GO:0061156) |
| 0.1 |
2.0 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
1.3 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
2.2 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.7 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.1 |
0.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
2.2 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 |
0.2 |
GO:2000018 |
regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) |
| 0.1 |
9.7 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.1 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
0.3 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
0.4 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.1 |
1.0 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
0.5 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.1 |
0.6 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.1 |
0.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.7 |
GO:0023058 |
adaptation of signaling pathway(GO:0023058) |
| 0.1 |
0.4 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 |
1.3 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.1 |
1.5 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
0.4 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.5 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 |
0.4 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
1.3 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.1 |
0.5 |
GO:0061036 |
positive regulation of cartilage development(GO:0061036) |
| 0.1 |
0.1 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 |
0.3 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.1 |
0.4 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
1.4 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.6 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.0 |
0.4 |
GO:0032648 |
regulation of interferon-beta production(GO:0032648) |
| 0.0 |
0.4 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.3 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
1.8 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.0 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.0 |
0.7 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
2.3 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.2 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.0 |
0.3 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.6 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.8 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.5 |
GO:0006289 |
nucleotide-excision repair(GO:0006289) |
| 0.0 |
1.4 |
GO:0009411 |
response to UV(GO:0009411) |
| 0.0 |
0.2 |
GO:0050707 |
regulation of cytokine secretion(GO:0050707) positive regulation of cytokine secretion(GO:0050715) |
| 0.0 |
0.4 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.5 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.0 |
0.1 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 |
0.1 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
0.6 |
GO:0006073 |
glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
| 0.0 |
0.1 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.0 |
0.9 |
GO:0010001 |
glial cell differentiation(GO:0010001) |
| 0.0 |
0.8 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.8 |
GO:0030855 |
epithelial cell differentiation(GO:0030855) |
| 0.0 |
1.1 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.0 |
0.7 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.0 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.1 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.0 |
0.5 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.6 |
GO:2000816 |
negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
3.8 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.0 |
0.0 |
GO:0046078 |
pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.0 |
0.3 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.0 |
0.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
1.0 |
GO:0035914 |
skeletal muscle cell differentiation(GO:0035914) |
| 0.0 |
1.7 |
GO:0019827 |
stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
| 0.0 |
0.3 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.3 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.0 |
0.0 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.0 |
0.0 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.1 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.0 |
0.1 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.0 |
0.3 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.4 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.0 |
0.1 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.1 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.3 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.2 |
GO:0042493 |
response to drug(GO:0042493) |
| 0.0 |
0.3 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.0 |
0.1 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.0 |
0.1 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.1 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 |
0.7 |
GO:0051262 |
protein tetramerization(GO:0051262) |
| 0.0 |
0.1 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.2 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.0 |
0.2 |
GO:0060021 |
palate development(GO:0060021) |
| 0.0 |
0.1 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
